NCT07073443 · ACTIVE NOT RECRUITING
Evaluation of the Effect of Memory-based Reminiscence Therapy
This trial is testing a structured reminiscence therapy — using personal memories as a therapeutic tool — to see whether it improves mental state, psychological flexibility, and cognitive flexibility in older adults with early-stage dementia (Stages 0 through 2). It is a behavioral, non-drug intervention. Phase NA means this is not a traditional drug-efficacy trial but rather a structured study evaluating a therapeutic approach.
You may qualify if
- Receiving outpatient treatment for dementia from the relevant departments of hospitals
- At the time of the interviews, the doctor must have diagnosed mild dementia. (Stages 0, 1, and 2)
- No problems with understanding or speaking Turkish
- Being literate
- Being in the 65 and older age group
- No other psychiatric or neurological disorders
You're excluded if
- Not having been diagnosed with dementia during the study
- Having other chronic cognitive and psychiatric illnesses
- Being in an advanced stage of dementia
- Those who withdrew from the study during the interview or refused to participate in the study
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-07-18